Actively Recruiting

All Genders
ID05328050

Local Registry for Data Collection of Patients With Achondroplasia / Hypochondroplasia for Epidemiological, Care and Research Studies

Led by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Updated on 2022-04-28

200

Participants Needed

1

Research Sites

261 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are collecting clinical data from patients diagnosed with achondroplasia and hypochondroplasia through an observational registry study. This study aims to gather information to support epidemiological research, care improvements, and scientific studies related to these conditions. The registry is managed by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico and will continue for at least 10 years. The study involves enrolling patients with confirmed diagnoses of achondroplasia or hypochondroplasia. There are no specific interventions or treatments given as part of this study, as it is observational and focuses on data collection only. Participants are registered and their health data is recorded and monitored over time to aid research and care. Participants will provide informed consent, and their clinical information will be collected and stored in the registry for up to 10 years. The primary outcome measure is the establishment and maintenance of a registry for these patients. There are no experimental procedures; instead, patient data is reviewed to understand disease characteristics and outcomes better. This long-term data collection helps researchers and clinicians improve understanding and management of achondroplasia and hypochondroplasia.

CONDITIONS

Brief Title

Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Confirmed diagnosis of achondroplasia or hypochondroplasia
  • Patients or their legal guardians able to provide informed consent
Not Eligible

You will not qualify if you...

  • No diagnosis of achondroplasia or hypochondroplasia
  • Patients or their legal guardians unable to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 10 years

Participants who undergo routine care are observed. Measurements are collected before and after routine healthcare.

Visits scheduled according to routine care

Trial Site Locations

Total: 1 location

1

Medical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan

Milan, Italy, 20122

Actively Recruiting

Loading map...

Research Team

M

Maria Francesca Bedeschi, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Phase 2b Trial Evaluating Weekly Subcutaneous Navepegritid...

Achondroplasia

Actively Recruiting

5 locations

A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Co...

Achondroplasia

Actively Recruiting

18 locations

A Multicenter Multinational Observational Study of Children ...

Hypochondroplasia

Actively Recruiting

43 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here